ALLMedicine™ Polymyositis Center

May 3rd, 2021 - To assess the clinical profile of patients with anti-polymyositis/Scl (PM/Scl) antibodies in a cohort of Spanish patients with systemic sclerosis. From the Spanish Scleroderma Study Group database, we selected patients in whom PM/Scl antibodies ha...

Apr 30th, 2021 - UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.|2021|Yang X,Yao H,Zhao Q,Zhao Q,Yan X,|

Apr 30th, 2021 - Polymyositis (PM) and dermatomyositis (DM) are autoimmune-mediated multisystemic myopathies, characterized mainly by proximal muscle weakness. A connection between epilepsy and PM/DM has not been reported previously. Our study aim is to evaluate t...

Apr 14th, 2021 - We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences in myositis patients with AMA. We screened sera from myositis patients includi...

Apr 13th, 2021 - Severe digital ischemia (SDI), which presents with digital ulcers, necrosis, or gangrene, has been reported to be a rare manifestation of anti-aminoacyl transfer RNA synthetase (ARS) antibody-positive polymyositis/dermatomyositis or anti-synthetas...

Dec 18th, 2018 - Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty. The aim of the present study was to establish the trea...

Apr 7th, 2017 - To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement ...

Sep 17th, 2009 - Consensus statements are important for developing treatment recommendations when evidence- based medicine (EBM) and treatment based on controlled trials is sparse or nonexistent. In this setting, it is clinically helpful to assemble a group of exp.

May 3rd, 2021 - To assess the clinical profile of patients with anti-polymyositis/Scl (PM/Scl) antibodies in a cohort of Spanish patients with systemic sclerosis. From the Spanish Scleroderma Study Group database, we selected patients in whom PM/Scl antibodies ha...

Apr 30th, 2021 - UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.|2021|Yang X,Yao H,Zhao Q,Zhao Q,Yan X,|

Apr 30th, 2021 - Polymyositis (PM) and dermatomyositis (DM) are autoimmune-mediated multisystemic myopathies, characterized mainly by proximal muscle weakness. A connection between epilepsy and PM/DM has not been reported previously. Our study aim is to evaluate t...

Apr 14th, 2021 - We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences in myositis patients with AMA. We screened sera from myositis patients includi...

Apr 13th, 2021 - Severe digital ischemia (SDI), which presents with digital ulcers, necrosis, or gangrene, has been reported to be a rare manifestation of anti-aminoacyl transfer RNA synthetase (ARS) antibody-positive polymyositis/dermatomyositis or anti-synthetas...

Feb 18th, 2021 - Home-based subcutaneous immune globulin therapy is a promising alternative to intravenous immune globulin therapy for patients with refractory dermatomyositis or polymyositis, Anna Postolova, MD, MPH, declared at the 2021 Rheumatology Winter Clini...

Oct 15th, 2019 - Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found. In a nationally representative cohort study, the incidence...

Feb 27th, 2019 - Amyloid PET imaging may help to accurately identify inclusion body myositis and distinguish it from polymyositis, which could potentially avoid misdiagnosis and unnecessary immunosuppressive medication, according to findings from a small prospecti.

Feb 20th, 2019 - Overlap Sometimes patients with polymyositis also have other rheumatologic conditions that shouldn’t be overlooked, therefore “overlap is its own category,” she said. “In our experience, the most common overlap is scleroderma,” she noted, adding t.

Jul 18th, 2018 - Action Points Be aware that patients with idiopathic inflammatory myopathies have double the risk of both ischemic and hemorrhagic stroke compared to the general population, according to a Swedish population-based cohort study. Note that the idiop...